A framework for economic evaluation of therapeutic drug monitoring—guided dosing in oncology
Abstract The standard approach for dose individualization of chemotherapy in the oncology setting has long been based on body surface area (BSA) as a measure of body size. However, for many anticancer drugs, administration of dosages based on BSA may result in some patients receiving supratherapeuti...
Guardado en:
Autores principales: | Daniel Erku, Jennifer Schneider, Paul Scuffham |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cb74d7419184c139d1f9e507ac548a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
por: Dreesen E, et al.
Publicado: (2017) -
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
por: Feng Z, et al.
Publicado: (2021) -
A framework to guide dose & regimen strategy for clinical drug development
por: Oliver Sander, et al.
Publicado: (2021) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Kashif Hussain, et al.
Publicado: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Christoph Tiede, et al.
Publicado: (2021)